SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 35.89

Change

+0.07 (+0.20)%

Market Cap

N/A

Volume

1.16M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-28 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

+0.84 (+0.19%)

USD 104.84B
REGN Regeneron Pharmaceuticals Inc

+0.94 (+0.14%)

USD 78.92B
ARGX argenx NV ADR

+6.65 (+1.03%)

USD 39.62B
ALNY Alnylam Pharmaceuticals Inc

-5.20 (-1.86%)

USD 30.22B
MRNA Moderna Inc

-4.22 (-9.39%)

USD 18.29B
RPRX Royalty Pharma Plc

+0.01 (+0.03%)

USD 18.12B
SMMT Summit Therapeutics PLC

-1.86 (-7.91%)

USD 17.52B
UTHR United Therapeutics Corporatio..

+1.90 (+0.51%)

USD 15.91B
INCY Incyte Corporation

+0.57 (+0.78%)

USD 13.41B
BMRN Biomarin Pharmaceutical Inc

+0.21 (+0.33%)

USD 12.74B

ETFs Containing SWTX

HFIN:CA Hamilton Enhanced Canadia.. 10.41 % 0.00 %

-0.04 (-0.20%)

CAD 0.19B
HLIF:CA Harvest Canadian Equity I.. 3.45 % 0.00 %

N/A

CAD 0.12B
XMV:CA iShares MSCI Canada Minim.. 2.88 % 0.33 %

+0.02 (+-0.20%)

CAD 0.25B
CDEF:CA Manulife Smart Defensive .. 2.58 % 0.00 %

N/A

CAD 1.40M
TLV:CA Invesco S&P/TSX Composite.. 2.34 % 0.34 %

N/A

CAD 0.07B
XMD:CA iShares S&P/TSX Completio.. 1.87 % 0.61 %

+0.15 (+-0.20%)

CAD 0.25B
CNCR Loncar Cancer Immunothera.. 0.00 % 0.79 %

-0.09 (-0.20%)

USD 0.01B
DXM:CA 0.00 % 0.67 %

N/A

N/A
FIE:CA iShares Canadian Financia.. 0.00 % 0.97 %

N/A

CAD 1.09B
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

+0.10 (+-0.20%)

CAD 0.09B
HEF:CA 0.00 % 0.83 %

N/A

N/A
HPR:CA Global X Active Preferred.. 0.00 % 0.63 %

-0.03 (-0.20%)

CAD 1.06B
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

-0.01 (-0.20%)

CAD 0.08B
IDNA iShares Genomics Immunolo.. 0.00 % 0.00 %

-0.17 (-0.20%)

USD 0.12B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

+0.05 (+-0.20%)

N/A
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

+0.02 (+-0.20%)

CAD 0.34B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

-0.02 (-0.20%)

N/A
TQCD:CA TD Q Canadian Dividend ET.. 0.00 % 0.00 %

+0.06 (+-0.20%)

CAD 0.38B
CDIV:CA Manulife Smart Dividend E.. 0.00 % 0.00 %

+0.02 (+-0.20%)

CAD 0.62B
TPIF Timothy Plan Internationa.. 0.00 % 0.00 %

-0.04 (-0.20%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.66% 57% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.66% 57% F 38% F
Trailing 12 Months  
Capital Gain -18.12% 58% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.12% 58% F 31% F
Trailing 5 Years  
Capital Gain 6.28% 79% B- 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.28% 79% B- 47% F
Average Annual (5 Year Horizon)  
Capital Gain 15.44% 62% D 68% D+
Dividend Return 15.44% 62% D 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 63.89% 54% F 31% F
Risk Adjusted Return 24.17% 80% B- 56% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector